US equities
|
NVDA
$240.44
▲+0.64%
SPCX
$172.93
▲+1.07%
MU
$1,066.71
▲+0.26%
MRVL
$288.36
▲+6.31%
AMD
$655.42
▲+3.75%
INTC
$115.23
▼-0.83%
AVGO
$379.52
▲+4.69%
TSLA
$380.30
▲+0.41%
NVDA
$240.44
▲+0.64%
SPCX
$172.93
▲+1.07%
MU
$1,066.71
▲+0.26%
MRVL
$288.36
▲+6.31%
AMD
$655.42
▲+3.75%
INTC
$115.23
▼-0.83%
AVGO
$379.52
▲+4.69%
TSLA
$380.30
▲+0.41%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Silexion Therapeutics
Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer
September 24, 2024
From
Silexion Therapeutics
Via
Business Wire
Tickers
SLXN